CIK 0001642380 · Non-accelerated filer<br>Smaller reporting company
Insight Molecular Diagnostics Inc.
Sign in to watch- Ticker
- IMDX
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- operating
- EIN
- 271041563
- Phone
- 949-409-7600
- Business address
- 2 INTERNATIONAL PLAZA DR., SUITE 510, NASHVILLE, TN, 37217
- Former names
- OncoCyte Corp, Oncocyte Corp
- 8-K Event Material agreement · Acquisition or sale completed · New debt or obligation · Unregistered share sale · Regulation FD disclosure
- 4 Insider Changes in Ownership
- 10-K Report Annual Report
- 8-K Event Results of operations
- D Other Notice of Sales of Unregistered Securities
- CERT Other Certification
- 25 Other Notification of Removal from Listing
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 8-A12B Other Registration of Securities
- 8-K Event Executive or director change
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 8-K Event Acquisition or sale completed · Delisting notice · Unregistered share sale · Regulation FD disclosure
- 8-K Event Regulation FD disclosure
- SC 13G/A Stake Amended Statement of Ownership
- 4 Insider Changes in Ownership
- SC 13D/A Stake Beneficial Ownership Report
- 424B5 Offering Prospectus
- 8-K Event Material agreement · Other events
Page 18 of 35 · 688 filings